LMS Mission & Message from the Director

Message from the Interim Director

Irene

Professor Irene Miguel-Aliaga, Interim Director of MRC LMS

“The LMS is an interdisciplinary research environment in which scientists and clinicians collaborate to advance the understanding of biology and its application to medicine.

The Institute was founded by the Medical Research Council over 20 years ago and now attracts the very highest caliber of scientists, postdoctoral fellows and students from around the world. Our collective challenge is to remain at the forefront of innovation so that advances made at the bench can be progressed for maximum benefit.

Close ties with colleagues at our sister institute the LMB in Cambridge, as well as Imperial College London, the Francis Crick Institute and universities across London, allow our scientists a unique opportunity to explore the genetic, epigenetic and physiological bases of health and disease and its visualisation through cutting-edge imaging.”

 

In March 2021 our Director Professor Dame Amanda Fisher announced her intention to step down from her role as Director of the MRC London Institute of Medical Sciences. While the process for a new Director is undertaken an interim leadership team has been appointed. Comprised of senior Programme Leaders Petra Hajkova, Stuart Cook, Irene Miguel-Aliaga and the LMS Head of Operations, Carole Swan. Irene will be the primary point of contact with MRC Head Office and Imperial College London and act as Interim Director for the Institute.

 

Institute’s mission and organisation

The LMS mission is:

  • To be at the forefront of innovative biomedical research, including the development of core competencies
  • In partnership with Imperial College London and others, to promote the translation of its research for maximum benefit
  • To train and mentor the next generation of leading clinical and non-clinical scientists
  • To enhance the public’s interest, understanding and trust in science

At the Hammersmith Campus, the LMS is based on a site, which contains two major teaching hospitals. It is therefore ideally placed to work with on-site partners to facilitate translational pull-through of its work. LMS scientists also exploit multidisciplinary opportunities with colleagues from Imperial College London combining biological sciences with other disciplines, in particular engineering, physics, mathematics, chemistry and computer science.

At full strength, the LMS comprises over 30 research groups organised into the two research sections Epigenetics and Genes and Metabolism. The research groups are also part of the Institute of Clinical Sciences (ICS), which is a Department in the Faculty of Medicine at Imperial College London. The ICS has three divisions Imaging Sciences, Clinical Research and Molecular Sciences.